UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

Cancer treatment reviews, 1997, Vol.23 (1), p.35-61

1997

Volltextzugriff (PDF)

110 EMT Followed in Three Dimensions in Vitro

European journal of cancer (1990), 2012-07, Vol.48, p.S27-S27

2012

Volltextzugriff (PDF)

Clinical Trials Review: Molecular Targeted Agents in Combination with Radiotherapy in Solid Tumors: A Pharmaceutical Industry Perspective

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S695-S695

2011

Volltextzugriff (PDF)

A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer

Critical reviews in oncology/hematology, 2017-04, Vol.112, p.80-102

2017

Volltextzugriff (PDF)

135 INVITED Combining molecular targeted agents with radiotherapy

European journal of cancer supplements, 2007, Vol.5 (4), p.37-37

2007

Volltextzugriff (PDF)

Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media

Magnetic resonance imaging, 2003-10, Vol.21 (8), p.845-851

2003

Volltextzugriff (PDF)

ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity

Microcirculation (New York, N.Y. 1994), 2002-12, Vol.9 (6), p.513-522

2002

Volltextzugriff (PDF)

The VEGF receptor tyrosine kinase inhibitor, ZD6474, inhibits angiogenesis and affects microvascular architecture within an orthotopically implanted renal cell carcinoma

Angiogenesis (London), 2004-12, Vol.7 (4), p.347-354

2004

Volltextzugriff (PDF)

Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer

Carcinogenesis (New York), 2006-10, Vol.27 (10), p.2133-2139

2006

Volltextzugriff (PDF)

ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity

Microcirculation (New York, N.Y. 1994), 2002, Vol.9 (6), p.513-522

2002

Volltextzugriff (PDF)

160 Antitumor therapy with VEGF receptor tyrosine kinase inhibitor ZD6474 in a mouse model of intestinal cancer

European journal of cancer supplements, 2004-09, Vol.2 (8), p.51-51

2004

Volltextzugriff (PDF)

Measurement of 5,10-dideaza-5,6,7,8-tetrahydrofolate (lometrexol) in human plasma and urine by high-performance liquid chromatography

Journal of chromatography. B, Biomedical applications, 1995-01, Vol.663 (2), p.327-335

1995

Volltextzugriff (PDF)

Mechanism of action of polymer-anthracyclines; potential to overcome multidrug resistance

Wedge, S.R

1991

Volltextzugriff (PDF)

Characterization of the fatigue behavior of additive friction stir-deposition AA2219

International journal of fatigue, 2021-01, Vol.142, p.105951, Article 105951

2021

Volltextzugriff (PDF)

Fatigue crack growth behavior of additively manufactured 17-4 PH stainless steel: Effects of build orientation and microstructure

International journal of fatigue, 2019-06, Vol.123, p.168-179

2019

Volltextzugriff (PDF)

Improved high cycle fatigue performance of additively manufactured 17-4 PH stainless steel via in-process refining micro-/defect-structure

Additive manufacturing, 2020-12, Vol.36, p.101604, Article 101604

2020

Volltextzugriff (PDF)

Characterization of the evolution of 2219-T87 aluminum as a function of the friction stir welding process

International journal of fatigue, 2021-01, Vol.142, p.105954, Article 105954

2021

Volltextzugriff (PDF)

165 AZD2171, a potent VEGF receptor tyrosine kinase inhibitor, combined with mechanistically distinct antitumor therapies in vivo

European journal of cancer supplements, 2004-09, Vol.2 (8), p.52-52

2004

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)
Dissertationen
(1)

Sprache

Englisch
(18)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

110 EMT Followed in Three Dimensions in Vitro

Clinical Trials Review: Molecular Targeted Agents in Combination with Radiotherapy in Solid Tumors: A Pharmaceutical Industry Perspective

A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer

135 INVITED Combining molecular targeted agents with radiotherapy

Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media

ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity

The VEGF receptor tyrosine kinase inhibitor, ZD6474, inhibits angiogenesis and affects microvascular architecture within an orthotopically implanted renal cell carcinoma

Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer

ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity

160 Antitumor therapy with VEGF receptor tyrosine kinase inhibitor ZD6474 in a mouse model of intestinal cancer

Measurement of 5,10-dideaza-5,6,7,8-tetrahydrofolate (lometrexol) in human plasma and urine by high-performance liquid chromatography

Mechanism of action of polymer-anthracyclines; potential to overcome multidrug resistance

Characterization of the fatigue behavior of additive friction stir-deposition AA2219

Fatigue crack growth behavior of additively manufactured 17-4 PH stainless steel: Effects of build orientation and microstructure

Improved high cycle fatigue performance of additively manufactured 17-4 PH stainless steel via in-process refining micro-/defect-structure

Characterization of the evolution of 2219-T87 aluminum as a function of the friction stir welding process

165 AZD2171, a potent VEGF receptor tyrosine kinase inhibitor, combined with mechanistically distinct antitumor therapies in vivo

Suchergebnisse filtern